
CAS 325970-71-6
:Formel:C16H14Br2N4O4
InChl:InChI=1S/C16H14Br2N4O4/c1-9-13(17)5-11(6-14(9)18)19-8-16(24)21-20-7-10-4-12(22(25)26)2-3-15(10)23/h2-7,19,23H,8H2,1H3,(H,21,24)/b20-7+
InChI Key:KFEPVFJQVOMODD-IFRROFPPSA-N
SMILES:CC1=C(C=C(C=C1Br)NCC(=O)N/N=C/C2=C(C=CC(=C2)[N+](=O)[O-])O)Br
Filtern nach
Reinheitsanteil
0
100
|
0
|
50
|
90
|
95
|
100
6 Produkte gefunden.
- Niedrigster Preis
- Höchster Preis
- Niedrigste Reinheit
- Höchste Reinheit
- Schnellste Lieferung
Glycine, N-(3,5-dibroMo-4-Methylphenyl)-, 2-[(2-hydroxy-5-nitrophenyl)Methylene]hydrazide
CAS:Formel:C16H14Br2N4O4Reinheit:95%Molekulargewicht:486.1148L67
CAS:2-((3,5-Dibromo-4-methylphenyl)amino)-N'-(2-hydroxy-5-nitrobenzylidene)acetohydrazideFormel:C16H14Br2N4O4Reinheit:98+%Molekulargewicht:486.11L67
CAS:L67 (DNA Ligase Inhibitor) is a competitive human DNA ligase inhibitor, inhibits DNA ligases I and III (IC50: 10 μM).Formel:C16H14Br2N4O4Reinheit:98.34% - 99.56%Farbe und Form:SolidMolekulargewicht:486.115L67
CAS:L67 is a monoclonal antibody that binds to the protein gene sequences of herpes simplex virus, which leads to the inhibition of viral replication. It has been shown to have an inhibitory effect on cancer cells, and can also be used as a pharmacological agent. L67 has been shown to have potent inhibition against intracellular calcium levels and kinetic energy in cell culture. This drug is being developed for use in cancer treatment and other diseases with high levels of calcium.Formel:C16H14Br2N4O4Reinheit:Min. 95%Molekulargewicht:486.11 g/mol





